NanoViricides
NNVC
29 hedge funds and large institutions have $4.13M invested in NanoViricides in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 9 closing their positions.
80% more call options, than puts
Call options by funds: $293K | Put options by funds: $163K
1.3% more ownership
Funds ownership: 8.32% → 9.62% (+1.3%)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
7% less capital invested
Capital invested by funds: $4.44M → $4.13M (-$314K)
12% less funds holding
Funds holding: 33 → 29 (-4)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$497K |
| 2 |
Renaissance Technologies
New York
|
+$203K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$181K |
| 4 |
WBG
Wharton Business Group
Malvern,
Pennsylvania
|
+$78.5K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$62K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Jane Street
New York
| – | -$98K | -21,212 | Closed |
|
|
VF
27
Virtu Financial
New York
| – | -$92K | -19,793 | Closed |
|
28
Marshall Wace
London,
United Kingdom
| – | -$51K | -11,037 | Closed |
|
|
TRCT
29
Tower Research Capital (TRC)
New York
| – | -$13K | -2,767 | Closed |
|
30
Fidelity Investments
Boston,
Massachusetts
| – | -$214 | -47 | -94% |
|
|
RE
31
RBC Europe
London,
United Kingdom
| – | -$37 | -8 | Closed |
|
32
Bank of America
Charlotte,
North Carolina
| – | +$18 | +4 | +2% |
|
NNVC Hedge Fund Activity: Q4 2021 in Review
29 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q4 2021, worth a combined $4.13M — down 7.1% from $4.44M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of NNVC and 5 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 6 added.
The largest buyer was Vanguard Group, adding an estimated $497K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $130K sold.
- 29 institutional investors held NanoViricides (NNVC) as of Q4 2021, down from 33 in Q3 2021.
- Funds reported $4.13M of NanoViricides stock for Q4 2021, down 7.1% quarter-over-quarter.
- 5 funds opened new NanoViricides positions in Q4 2021 and 9 closed out, a net change of -4 holders.
- The largest NanoViricides buyer in Q4 2021 was Vanguard Group, an estimated $497K added.
- The largest NanoViricides seller in Q4 2021 was Susquehanna International Group, an estimated $130K sold.
Based on aggregated 13F filings for Q4 2021.